Atalanta Therapeutics founded by UMass Medical School and three faculty members
Atalanta Therapeutics, a biotech founded by UMass Medical School and three faculty research scientists to pioneer treatment options for neurodegenerative diseases, has launched with financing by venture capital fund F-Prime Capital and strategic collaborations with Biogen and Genentech.
Read more
, Graduate School of Biomedical Sciences, School of Medicine, Medicine, Clinician, Faculty, Craig C. Mello, Anastasia Khvorova, RNA Therapeutics Institute, Aronin Lab, Program in Molecular Medicine, Neil Aronin,
Jan 31, 2022
Biomedical sciences student works toward a future in genetic engineering
PhD student Katya Makeyeva investigates how small RNA pathways regulate gene expression of reproductive cells in the lab of Nobel Laureate Craig Mello, PhD.
Read more
, Graduate School of Biomedical Sciences, Faculty, Student, Craig C. Mello, RNA Therapeutics Institute, Student Spotlight, Latest News, Mello Lab,
Oct 7, 2024
Champagne toast raised as Nobel winner reacts to news
Although Victor Ambros, PhD, was scheduled to move his lab into a new building today, the announcement that he and Gary Ruvkun, PhD, were awarded the Nobel Prize in Physiology or Medicine for their discovery of microRNA, put those plans were put on hold. Read more about how his day unfolded.
Read more
, Graduate School of Biomedical Sciences, School of Medicine, Clinician, Faculty, Michael F. Collins, Craig C. Mello, Research, RNA Therapeutics Institute, Ambros Lab, Program in Molecular Medicine, Victor Ambros, Latest News, Top Stories, Nobel,
Oct 9, 2024
Video: Nobel Laureate Victor Ambros celebrates with UMass Chan community
The UMass Chan Medical School community embraced its newest Nobel Laureate on Monday, Oct. 7, after Victor Ambros, PhD, was named the co-recipient of the 2024 Nobel Prize in Physiology or Medicine for his co-discovery of microRNA. See how the day unfolded in this video.
Read more
, Graduate School of Biomedical Sciences, School of Medicine, Clinician, Student, Michael F. Collins, Craig C. Mello, Research, Postdoctoral Scholar, Terence Flotte, Flotte Lab, Pediatrics, RNA Therapeutics Institute, Ambros Lab, Program in Molecular Medicine, Victor Ambros, Latest News, Top Stories, Media, Nobel,
Oct 17, 2024
UMass Chan ‘takes pride in calling you one of our own,’ Chancellor tells Nobel-recipient Victor Ambros
Victor Ambros, PhD, shared his gratitude to his wife and collaborator, Rosalind “Candy” Lee, as well as to the Medical School and scientific community, at a celebration of the Nobel Prize in Physiology or Medicine he co-received with Gary Ruvkun, PhD, professor at Harvard Medical School, for their discovery of microRNA.
Read more
, Graduate School of Biomedical Sciences, School of Medicine, Faculty, Michael F. Collins, Craig C. Mello, Research, Event, Terence Flotte, RNA Therapeutics Institute, Ambros Lab, Program in Molecular Medicine, Victor Ambros, Latest News, Top Stories, Media, Nobel,
Oct 9, 2024
Nobel-worthy mentorship: Students rejoice after mentor Victor Ambros wins 2024 Nobel Prize
Students in the Ambros lab at UMass Chan Medical School and 2006 Nobel Prize winner Craig Mello, PhD, celebrated their mentor, Victor Ambros, PhD, as he received the Nobel Prize in Physiology or Medicine with Gary Ruvkun, PhD, for their discovery of microRNA.
Read more
, Graduate School of Biomedical Sciences, School of Medicine, Faculty, Craig C. Mello, Research, RNA Therapeutics Institute, Ambros Lab, Microbiology and Physiological Systems, Program in Molecular Medicine, Victor Ambros, Latest News, Mello Lab, Top Stories, Nobel,
Aug 21, 2023
NIH funds Kirschstein Award recipient Johan Girgenrath’s fertility research
PhD candidate John Girgenrath has received a competitive award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development to conduct fertility research.
Read more
, Graduate School of Biomedical Sciences, Student, Craig C. Mello, Award, Research, Interdisciplinary, RNA Therapeutics Institute, Program in Molecular Medicine, Latest News, Mello Lab, Top Stories,
Dec 18, 2020
Inside the new mRNA vaccines for COVID-19
The new vaccines by Pfizer/BioNTech and Moderna use messenger RNA to stimulate the immune system to protect against COVID-19. These vaccines are the first of their kind and researchers at UMass Medical School are among the leading RNA biologists in the world.
Read more
, Graduate School of Biomedical Sciences, School of Medicine, Office of Advancement, Faculty, Craig C. Mello, Anastasia Khvorova, Jonathan K. Watts, Novel Coronavirus, Biochemistry and Molecular Biotechnology, RNA Therapeutics Institute, Ambros Lab, Phillip Zamore, Program in Molecular Medicine,
Jun 14, 2022
Biomedical sciences student studying fertility in Mello lab
Movies piqued PhD candidate Humberto Ochoa’s interest in science. He’s conducting RNA research in the lab of Nobel Laureate Craig C. Mello, PhD, to understand the national decline in fertility.
Read more
, Graduate School of Biomedical Sciences, Faculty, Student, Craig C. Mello, Interdisciplinary, RNA Therapeutics Institute, Student Spotlight, Latest News, Mello Lab,
Oct 30, 2024
UMass leaders share research system success during Medical School visit from ARPA-H director
UMass Chan and the entire UMass ecosystem are poised for further breakthrough advances in biomedical research, university leaders and congressional delegation members tell ARPA-H director at Medical School visit.
Read more
, School of Medicine, Faculty, Michael F. Collins, Craig C. Mello, Research, Program in Molecular Medicine, Victor Ambros, Latest News,